Moreover, TIGIT blockade presents anti-tumor efficacy in Tgfbr1/Pten2 conditional knock-out (KO) mouse model that spontaneously develops head and neck squamous cell carcinoma (HNSCC) upon tamoxifen injection [55,65]. Here, TGFBR1 is linked to head and neck squamous cell carcinoma.